Vertex Pharmaceuticals is relatively new to the type 1 diabetes space, and they are working hard to understand what it’s like for people to live with T1D so they can develop transformative therapies. They’re currently investigating and advancing cell therapies aimed at treating an underlying cause of type 1 – the absence of insulin-producing cells.
read more →Dr. Ian Paterson, a medical practitioner at the University of Sheffield who lives with T1D, explains how the “honeymoon phase” that often occurs with type 1 can potentially be used to delay its full development, and why it’s important to preserve even a small number of functioning beta cells if you can.
read more →Do you know it’s now possible to screen for type 1 diabetes? Learn why it could be important for you and your family, and how it can help you understand more about the risks, development, and progression of T1D.
read more →Who knew diabetes was a double dipper? It doesn’t seem fair that anyone could end up with both type 1 and type 2 diabetes at the same time, but it can happen. Learn who’s most susceptible to this double diagnosis, which treatments are recommended, and how you can actually work the diagnosis to your advantage.
read more →Keep your eyes peeled for Dr. Pettus parachuting into your backyard with glee in response to the results of a study on mortality rates and type 1. You might want to start saving now for pickleball paddles and your dream retirement custom RV…living a long life with T1D is lookin’ good!
read more →




